Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1051751.RA673MXkwZw1cFNy_FwBPNVpVNqz7Z0DkmktT23j-kkI8#assertion> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[The data suggest that the ability of sorafenib to activate GSK-3? and alter the intracellular distribution of p53 may be exploitable as an adjunct to agents that prevent the HDM2-dependent degradation of p53 in the treatment of melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion evidence source_evidence_literature provenance.
- assertion SIO_000772 21929745 provenance.
- assertion wasDerivedFrom BEFREE provenance.
- assertion wasGeneratedBy ECO_0000203 provenance.